Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Two New Ros/MucR Proteins: An Atypical Structure with a Divergent Function.

Biomolecules·2026
Same author

Identification of the first peptide inhibitor of UBE2C enzymatic activity: insights from metadynamics-guided folding and binding studies.

Journal of enzyme inhibition and medicinal chemistry·2026
Same author

Solvent-free reactions at work towards densely functionalized targets: synthesis of 3-amino(azido)-3-deoxy-D-galactose, a key structural motif of galectin ligands.

Organic & biomolecular chemistry·2025
Same author

In-Depth Analysis of the Paramagnetic Properties in DHI/DHICA-Controlled Eumelanin.

ACS omega·2025
Same author

Three semi-synthetic approaches to a set of curdlan sulfate polysaccharides with different sulfation patterns.

Frontiers in molecular biosciences·2025
Same author

Synthesis of Ethylphosphonate Curcumin Mimics: Substituents Allow Switching Between Cytotoxic and Cytoprotective Activities.

Antioxidants (Basel, Switzerland)·2025
Same journal

Impact of an Artificial Albumin Corona on Surface Charge-Driven Nano-Bio Interactions and Cytotoxicity of Silver Nanoparticles.

ACS omega·2026
Same journal

Structural and Functional Disruption of Thiopurine S‑Methyltransferase by the A80P Variant: A Simulation and Genotyping Study.

ACS omega·2026
Same journal

CRISPR/Cas12a2-Mediated Ultrasensitive Assay for Rapid Detection of H1N1 Influenza Virus RNA.

ACS omega·2026
Same journal

Photocatalytic Treatment of Real Sugar Industry Wastewater Using Lignocellulosic Biomass-Derived Hydrochar/g-CN.

ACS omega·2026
Same journal

Electrochemical Dopamine Biosensor Based on Plant-Derived Peroxidase Immobilized on Titanate Nanowires.

ACS omega·2026
Same journal

Revealing the Effects of Process Parameters on Structural, Thermal, Mechanical, Biodegradation, and Biocompatibility Properties on the Electrospinning of Poly(vinyl alcohol)/Microbial Inulin Nanofibers.

ACS omega·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling
11:08

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling

Published on: February 5, 2018

9.3K

Melanin Building Block as Scaffold for Dynamic Submicromolar Galectin Inhibitors.

Emanuele Carrella1, Luciano Pirone2, Rita Russo2

  • 1Department of Physics Ettore Pancini, University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.

ACS Omega
|April 13, 2026
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel multivalent ligand using a biocompatible eumelanin backbone to inhibit galectin-3. This promising approach offers a new strategy for developing selective galectin inhibitors for therapeutic applications.

More Related Videos

Author Spotlight: Unveiling the Structural and Dynamic Aspects of Glycan Molecular Recognition
07:40

Author Spotlight: Unveiling the Structural and Dynamic Aspects of Glycan Molecular Recognition

Published on: May 17, 2024

2.2K
Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

16.4K

Related Experiment Videos

Last Updated: Apr 14, 2026

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling
11:08

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling

Published on: February 5, 2018

9.3K
Author Spotlight: Unveiling the Structural and Dynamic Aspects of Glycan Molecular Recognition
07:40

Author Spotlight: Unveiling the Structural and Dynamic Aspects of Glycan Molecular Recognition

Published on: May 17, 2024

2.2K
Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

16.4K

Area of Science:

  • Biochemistry
  • Polymer Chemistry
  • Glycobiology

Background:

  • Galectins are β-galactoside-binding proteins implicated in various biological functions and diseases.
  • Developing selective galectin inhibitors, particularly multivalent ligands on biocompatible backbones, is crucial for therapeutic applications.

Purpose of the Study:

  • To synthesize and characterize a novel multivalent ligand for galectin-3 using a eumelanin-based backbone.
  • To investigate the interaction between the synthesized ligand and galectin-3.

Main Methods:

  • Oxidative polymerization of 5,6-dihydroxyindole (DHI) to create a eumelanin backbone.
  • Nuclear magnetic resonance (NMR) spectroscopy for complete characterization.
  • UV-vis spectrometry, dynamic light scattering (DLS), isothermal titration calorimetry (ITC), and biolayer interferometry (BLI) to study protein-ligand interactions.

Main Results:

  • Successful synthesis and characterization of a submicromolar multivalent ligand of galectin-3.
  • Quantification of galectin-3-ligand binding affinity (KD) using multiple biophysical techniques.
  • Proposal of a model for galectin-3-polymer interaction.

Conclusions:

  • Eumelanin-based multivalent ligands represent a promising platform for developing high-performance, selective galectin-3 inhibitors.
  • The developed ligand demonstrates potential for therapeutic applications targeting galectin-related diseases.
  • This study provides insights into protein-polymer interactions relevant to biomaterials and drug development.